Prayut told reporters that the government had not barred the private sector from procuring vaccines, but complex import regulations were a barrier.
The PM said the government was ready to simplify the import procedures for privately procured vaccines providing they were in line with global standards. But he cautioned that high global demand for vaccines meant manufacturers might not be ready to sell to Thailand.
However, 1.5 million doses of government-procured vaccine would arrive this month, Prayut added.
Thailand is in a race to vaccinate its population of 69 million people as a third wave of infections triggers targeted lockdowns across the country.
Ladprao General Hospital (LPH) has revealed plans to import vaccine brands other than the AstraZeneca and Sinovac jabs procured by the government.
LPH expects to receive its first batch of imported vaccine in the fourth quarter of this year.
Currently, three vaccine brands have been registered for use in Thailand – China's Sinovac Biotec, AstraZeneca and Johnson & Johnson.
India’s Covaxin is pending registration in Thailand while suppliers of three other brands – Moderna, Sputnik V and Sinopharm – are in talks with the Thai FDA.
Published : April 09, 2021
By : THE NATION